Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
13,713 total articles
Meta just kicked off a new growth phase with Muse and integrated AR/VR devices. Fundamentals still backstop the story (free cash flow ~$41B, P/E ~28x), technicals are constructive, and the stock sits above key moving averages. This is a trade idea to ride the mid-term momentum while protecting capital with a tight stop.
Etsy is a profitable, asset-light marketplace with free cash flow and a user base primed for AI-driven discovery. With the stock trading near $67 and technicals showing short-term oversold conditions, a disciplined long helps capture upside if AI features convert millions of small "mask moments" into purchases. Entry $67.34, stop $58.00, target $85…
Apple's fundamentals have shifted from 'expensive-but-stable' to 'expensive-with-improving-economics.' Higher margins and robust free cash flow justify a rating upgrade. This is a long trade: enter at $341.04, stop at $320.00, target $380.00 over a long-term (180 trading days) horizon.
Forward Industries (FWDI) sells at a material discount to the implied value of its Solana treasury and operational optionality. A $25M registered direct offering at $8.00 completed on 09/24/2026 replenishes dry powder to buy SOL and increases SOL-per-share; combined with a tight float and rising technical momentum, the setup favors a tactical long …
Amrize (HCMLF) looks set to benefit from improving gross margins and resilient end markets. We outline a tactical long trade with clear entry, target, and stop, a 45 trading-day horizon, and a risk-aware plan. Key catalysts include margin normalization, order flow improvement, and potential positive commentary at the next trading update.
Riley Exploration Permian (REPX) trades like a deep-value Permian E&P with an EV/EBITDA of ~3.9x, a P/E under 8x and a $0.40 quarterly dividend. If Riley can deliver ~30% oil growth over the next year, the stock can re-rate toward mid-single-digit EV/EBITDA multiples and deliver meaningful upside. This trade outlines an entry at $40.56, a stop at $…
Sportradar (SRAD) trades at $13.25 with a $4.13B market cap. A potential strategic lift from a Meta connection could re-rate growth expectations, but class-action suits and aggressive short positioning mean I want confirmation before committing capital. Trade plan: enter at $13.25, stop $11.50, target $18.00 for a mid-term swing (45 trading days).
Cohu has already rallied hard on AI-driven test demand. Recent results and guidance show revenue growth and margin improvement that should justify further upside near-term. This is a tactical long for traders who want to ride earnings normalization into the stock while using a tight stop to limit downside if the cycle stalls.
Syntec Optics is showing real revenue and order momentum from space and biomedical customers, and Q2 commentary suggests an operational inflection. That said, the market has already bid the stock up aggressively — valuation metrics are rich, insider ownership and low free cash flow amplify execution risk, and short interest and short-volume activit…
Nvidia's share price has pulled back enough that its earnings and free cash flow profile look compelling versus current growth expectations. With data-center GPU demand still strong, excellent profitability and a fortress balance sheet, I'm upgrading NVDA to a Buy. Below is an actionable trade plan with entry, stop and target levels and a balanced …
BRP reported a Q2 net loss and suspended FY27 guidance after new U.S. tariffs drove a material near-term cost shock. The stock is down from its 52-week high and trading near $57. I argue a measured long here—entry $56.00, stop $50.00, target $72.00—offers attractive asymmetric upside over a mid-term window (45 trading days) if management executes o…
CenterPoint Energy is trading at multi-month lows as sector sentiment and rate‑sensitivity have driven the stock below key moving averages. Fundamentals remain intact — $24.3B market cap, stable regulated businesses, and a 2.45% yield — while technicals (RSI ~26.7) point to oversold conditions. This is a tactical mid‑term long trade: enter at $36.8…
Octave Intelligence is executing sensibly on AI-enabled efficiency products that are reducing costs and increasing recurring revenue, but recent results show total revenue slipping and management has not yet demonstrated that AI is reliably driving top-line expansion. The stock trades at a reasonable multiple with a $5.06B market cap; this trade bu…
Delek Logistics (DKL) yields ~8.3% after a dilutive 4 million-share offering at $50. Management is using proceeds to pay down debt and accelerate separation from its sponsor. The stock trades at a roughly $3.1B market cap with EV/EBITDA ~16.6x and FCF roughly $134M — attractive numbers for an asset-light midstream with strong third-party exposure, …
UnitedHealth (UNH) offers a pragmatic long trade: a $377 entry with a $420 target and $345 stop. The thesis rests on sizeable free cash flow ($23.6B), a diversified earnings engine (UnitedHealthcare + Optum), a healthy balance sheet (debt/equity ~0.74) and a 2.38% yield that compounds while the company invests in analytics and specialty pharmacy. T…
RTX sits on a record $289B backlog and improving order visibility; modest margin expansion and steady FCF conversion should re-rate the stock. Technicals are oversold and valuation leaves room for upside if Pratt & Whitney and RMD margins normalize. This trade targets $230 with a $170 stop over a 180-trading-day horizon.
Ingles Markets (IMKTA) is trading below tangible-value metrics despite steady free cash flow, a conservative balance sheet and regional scale. At roughly $1.6B market cap, a P/E near 19.6 and EV/EBITDA ~6.2, the stock looks cheap relative to its fundamentals and resilience. This trade idea lays out an entry at $83.50, stop at $77.00 and a target at…
Viemed Healthcare is a national provider of respiratory home healthcare whose improving capital efficiency, strong free cash flow and minimal leverage support a long trade. At a $339M market cap and EV/EBITDA ~6.2, the stock looks reasonably valued relative to its cash generation. This trade idea lays out entry, stop and target levels, catalysts to…
Lam Research sits squarely in the middle of the AI infrastructure upgrade. With management targeting mid-40% operating margins, Q1'27 guidance showing revenue of $8.1B and near-40% margins, and a compelling free cash flow profile, LRCX is a tradeable long for investors willing to accept valuation premium in exchange for durable growth and margin ex…
Eightco Holdings looks like a low-visibility small-cap that could re-rate if it proves out crypto revenue acceleration or an OpenAI-related product hook. This trade is a directional long with a defined entry, stop and two-tier target plan over a 180 trading-day horizon.
Shake Shack has been punished for near-term margin pressure and a trimmed guide, leaving the stock trading well below its 52-week high with attractive technical oversold indicators and a clear growth runway. This trade idea outlines a long entry with a tight stop, a 180-trading-day horizon toward a 2027 breakout, and explicit targets tied to valuat…
Nvidia remains the dominant supplier of AI compute, but at scale that dominance is priced in. This trade plan buys a tactical mid-term rebound while protecting capital with a defined stop. Entry at $225.08, target $285.00, stop $205.00 — mid term (45 trading days) thesis with clear catalysts and exit rules.
Syndax has moved from clinical-stage to commercial momentum: two approved therapies are generating material revenue and the company is positioned for additional upside from Revuforj geographic expansion and a Q4 2026 Niktimvo data release. The stock trades at ~$1.63B market cap with meaningful short interest; a successful data cadence or accelerati…
Campbell's reported another quarter of profit decline and cut its dividend, yet the shares trade near their 52-week low with a sub-1x price-to-sales and an attractive cash-flow profile. This trade idea targets a rebound as investors reprice the company for margin recovery and more credible debt reduction.
Micron's business is squarely in the middle of an AI-driven memory supercycle. With market cap ~$1.22T, trailing EPS of $44.69 and free cash flow of $26.17B, the company has delivered extraordinary earnings leverage this year. Enter a disciplined long ahead of fiscal Q4 (09/30/2026) with a $1,080 entry, $1,300 target and $930 stop — horizon: mid te…
